Insider · CIK 0001603271
Einhorn Irving M.
Reports to the SEC for 1 company · PORTLAND, OR
Transactions
7
Companies
1
Filings
6
CIK
0001603271
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2017-10-10 | SLSSELLAS Life Sciences Group, Inc.A Award | +$5,459.08 |
| 2017-07-06 | SLSSELLAS Life Sciences Group, Inc.A Award | +$5,404.99 |
| 2017-06-08 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award | — |
| 2017-04-10 | SLSSELLAS Life Sciences Group, Inc.A Award | +$5,096.42 |
| 2017-01-20 | SLSSELLAS Life Sciences Group, Inc.A Award | +$4,999.5 |
| 2016-07-14 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award | — |
| 2015-06-19 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Einhorn Irving M.0001394548-17-000029SEC(opens sec.gov)
- 4Galena Biopharma, Inc.0001394548-17-000026SEC(opens sec.gov)
- 4Galena Biopharma, Inc.0001394548-17-000014SEC(opens sec.gov)
- 4Galena Biopharma, Inc.0001394548-17-000010SEC(opens sec.gov)
- 4Galena Biopharma, Inc.0001390478-16-000124SEC(opens sec.gov)
- 4Galena Biopharma, Inc.0001250853-15-000061SEC(opens sec.gov)
Companies
Address
C/O GALENA BIOPHARMA, INC. 4640 SW MACADAM AVE, SUITE 270
PORTLAND, OR, 97239